Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (unaudited)

v3.3.0.814
Condensed Statements of Operations (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Income Statement [Abstract]        
Revenues
Operating expenses:        
Research and development $ 547,029 $ 159,883 $ 1,257,075 $ 405,215
General and administrative 531,841 246,182 1,467,759 914,399
Total operating expenses 1,078,870 406,065 2,724,834 1,319,614
Operating loss (1,078,870) (406,065) (2,724,834) (1,319,614)
Other income (expense):        
Interest income 1,451 193 3,650 440
Interest expense (1,755) $ (1,700) (5,267) $ (5,141)
Other expense (33) (1,452)
Amortization of debt discount (49) $ (49) (147) $ (284)
Total other expense (386) (1,556) (3,216) (4,985)
Net loss $ (1,079,256) $ (407,621) $ (2,728,050) $ (1,324,599)
Basic and diluted net loss per share $ (0.03) $ (0.03) $ (0.09) $ (0.1)
Weighted average common shares outstanding - basic and diluted 32,320,891 12,915,343 31,951,056 12,915,343